Now showing items 1-2 of 2
Economic evaluation of supplementing the diet with 1 Souvenaid in patients with prodromal Alzheimer's disease
(BioMed Central Ltd. Part of Springer Nature, 2020)
Background: The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid ...
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain
(Springer Nature, 2022)
Introduction The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether ...